GBCHealth News and Opportunities | June 2012

We are pleased to share with you the latest Global Fund Private Sector Delegation (PSD) newsletter covering updates, news and information on the PSD, the Global Fund and its Board.

This edition of the PSD Newsletter contains:

A Year in Review

The year 2012 saw major growth, reform and progress for the Global Fund. The Fund appointed as its executive director Mark Dybul, a widely recognized and visionary leader on global health and a member of GBCHealth’s Corporate Advisory Board. The Fund also revamped its grant-making model and extended a program that makes affordable antimalarial medicines more accessible around the world.

Global Fund-supported programs continued to have a greater impact than ever: on November 30, the Global Fund released results that showed a substantial increase since 2011 in the number of people being treated for HIV, in the prevention of mother-to-child transmission of the virus and other interventions. The results included:

  • A 27 percent increase in the number of people receiving ARVs, estimated at 4.2 million people since 2011
  • A 35 percent increase in the number of insecticide-treated nets distributed for malaria
  • A 46 percent increase in HIV care and support services provided to patients
  • An 88 percent increase in HIV behavioral change communications
  • An increase in the number of pregnant women receiving antiretroviral medicines to prevent the transmission of HIV to their unborn children from 1.3 million to 1.7 million

For more information, including a detailed table of results, read the Global Fund’s press release here.

GBCHealth Co-hosts Reception for Gabriel Jaramillo in China

Gabriel Jaramillo

On the occasion of Global Fund General Manager Gabriel Jaramillo’s World AIDS Day visit to China, GBCHealth, BD and the China Country Coordination Mechanism (Ministry of Health) hosted a private sector reception and dinner on December 4 in Shanghai, China. The event was attended by Jaramillo, Dr. Ren Minghui (Director-General of the China Ministry of Health’s Department of International Cooperation) and senior executives from a number of Chinese and multi-national companies, including Access Bank, The Coca-Cola Company, Desano Pharmaceuticals Co., Edelman, GE, Nike, Northeast Pharmaceutical Group, Rongheng International Trading Co., and Standard Chartered Bank. The intimate gathering offered a unique opportunity to dialogue with Jaramillo on the Global Fund’s mission, China’s global health engagement and opportunities for the private sector.

Dr. Ren made a few short remarks emphasizing the importance of the collaboration of the Chinese Ministry of Health and the Global Fund, while outlining key upcoming priorities for the Ministry. Jaramillo acknowledged the strong presence of corporate companies at the reception, while emphasizing the importance of further engaging more private sector companies in the fight against AIDS, TB and malaria. Read reception coverage here.

Global Fund Business Forum Meets in Bangkok

The Global Fund — in partnership with GBCHealth, Friends of the Global Fund Japan, Pacific Friends of the Global Fund and the Thailand Business Coalition on AIDS — convened a two-day business forum in Bangkok from July 11-12, 2012, bringing together regional business and government leaders. The forum, “Investing in Asia-Pacific: Public-Private Partnerships in Health,” was successful in raising regional private sector interest in the Global Fund. Several PSD member companies attended, including representatives from Abbott Labs, BD, Merck, Sumitomo Chemical and Vestergaard Frandsen.

Global Fund Business Forum: Investing in Asia Pacific

From left to right: Apichal Mongkol, Anthony Paramualratana, Dr. Christoph Benn, Dr. Paijit Warachit, Ken Shibusawa, Wendy McCarthy and Michael Schreiber

For more information about this event, please click here.

Highlights from the PSD Retreat and September Global Fund Board Meeting

Private Sector Advisory Group members participated in the Annual PSD Retreat and Pre-Board meeting on September 10-11 in Lyon, France, to discuss the key Global Fund Board decisions. The Advisory Group also discussed broader issues facing the Fund and priorities for the PSD. Read more about the retreat and the Global Fund’s September Board Meeting here.

Highlights from the November Global Fund Board Meeting

The 28th Global Fund Board Meetings took place from November 14-15 2012 in Geneva, Switzerland. Key agenda items included operationalizing the new funding model and selection of the Executive Director. The PSD held its pre-Board meeting on November 12 in Geneva, Switzerland, and an official delegation led by Dr. Brian Brink went on to represent the private sector at the 28th Board Meeting. Read more about the major decisions of the Global Fund’s November Board Meeting here.

High-Level PSD Leadership Changes

The terms of Private Sector Board Member Brian Brink (Anglo American) and Alternate Board Member Renuka Gadde (BD) will expire in mid-2013. GBCHealth has issued a call for nominations for the next Private Sector Board and Alternate Board Members for a term beginning at the Global Fund’s 29th Board Meetings in June 2013. For additional information regarding the nomination processes, please contact

Whitney White (Officer, Membership and Advisory Services, GBCHealth) has joined the PSD team in the role of interim Focal Point, having taken over from Anna Thompson-Quaye after her transition from GBCHealth in summer 2012. Whitney can be reached at A subcommittee of Advisory Group members will conduct a request for proposals this winter to identify the next Focal Point for a term beginning in 2013.

Understanding the Global Fund’s Financing Mechanism

The Global Fund has recently approved significant changes to its grant-making processes. A New Funding Model, replacing the former rounds-based model, was approved in a series of decision points at the September and November Board Meetings. The model will be implemented in select pilot countries in 2013, with full implementation taking place in 2014. For additional information regarding the new model, the former Rounds-based model and steps involved in obtaining a grant from the Global Fund, please click here.


Sumitomo Chemical

Sumitomo Chemical Olyset Ner

Sumitomo Chemical, one of the world’s largest hybrid chemical companies, is well known for its Olyset® technology. This technology has improved the efficacy of bed nets by providing long-lasting protection from malaria-spreading mosquitoes. Read more about the program here.



ThailandThailand has received $319 million in funding from the Global Fund since 2003. The country has made significant progress in addressing HIV/AIDS, TB and malaria but more education initiatives and awareness are crucial to maintain this progress. Read more about the Global Fund in Thailand here.

GBCHealth Annual Conference and Gala Dinner

May 15-17, 2013

Save the date for the 2013 GBCHealth Annual Conference: May 15th-17th, at the Roosevelt Hotel in New York City. Join the conversation with thought leaders in business and global health; participate in action-oriented sessions; and engage with colleagues new and old during extensive networking opportunities. This is the one business and health event of the year that you don’t want to miss! Register Now.

To get a sense of what you can expect, visit the 2012 GBCHealth Conference page where we have captured the big ideas, quotes and images from last year’s event.

The Private Sector Delegation (PSD) is hosted by GBCHealth

GBCHealth serves as the entry-point for the Private Sector to collaborate with the Global Fund. With dozens of committed businesses, GBCHealth orchestrates The Private Sector Delegation’s role, steering Global Fund priorities and policies, while also ensuring that the Global Fund actively engages the business sector.

For more information on how your company or private sector organization can get involved, please contact PSD Focal Point, Whitney White at Learn more about the Private Sector Delegation.


Date/Location TBD

1st Meeting of the Global Fund’s Fourth Replenishment

Week of April 1

Advisory Group Quarterly Teleconference


GBCHealth Annual Conference

New York City, USA.


PSD Pre-Board Meeting

Colombo, Sri Lanka


Global Fund Board Pre-Meetings

Colombo, Sri Lanka


Global Fund 29th Board Meetings

Colombo, Sri Lanka

Date/Location TBD

Launch of the Global Fund’s Fourth Replenishment and Pledging Conference


PSD Pre-Board Meeting

Geneva, Switzerland


Global Fund Board Pre-Meetings

Geneva, Switzerland


Global Fund 30th Board Meeting

Geneva, Switzerland

» Global Fund Appoints Norbert Hauser as Interim Inspector General.

» Full-scale HIV Program to Resume in Mali.

» Global Fund Appoints Mark Dybul as Executive Director.

» Global Fund Decides on Transition of New Approach for Funding Grants.

» Board Approves Intergration of AMFm into Core Global Fund Processes.

» Global Fund Terminates the Employment of Inspector General, John Parsons.

» Global Fund Appoints Elizabeth O’Donnell as Head of Human Resources.

» Global Fund Appoints Christopher Game as Chief Procurement Officer.

» Global Fund Appoints Sylvie Billion as Tresurer, Deputy CFO.

» Zambia and the GF Sign Agreement on US $120 million for HIV Programs.

» Zimbabwe to Attain Universal Coverage of AIDS Treatment by the End of 2012.

» Coca-Cola and the Global Fund announce partnership to help bring critical medicines to remote regions.

» ‘The Big Push’ campaign is launched to take on global health challenges.

» The Global Fund’s release of results report concludes that its treatment and prevention programs have been effective.

» Global Fund adopts new approach to funding grants.

» Global Fund approves $419.2 million in new grants under the Transitional Funding Model to finance essential services.

» Nigeria and the Global Fund sign grant agreements worth $225 million to fight malaria.